2nd TSX percentage gainersWe were second to a company that traded only 3000 shares! Dang!! We traded over 6.4mm shares on no news. Seems as though the run up to AdComm may have begun. There really does seem to be very little reason the advisory committee shouldn't vote in favor of MCNA on the 18th. Severe shortage of BCG. Essentially no treatment for refractory patients aside from removal of Bladder or palliative care. Valstar approved with 10% efficacy on less data than our Phase 3 and partial phase 3b. Our safety profile is like no other in the Oncology space. 1.5% mild to moderate AE compared to >30% for Valstar. Aside from some sort of sinister plot, I cannot imagine we won't get a thumbs up on November 18th. $2++ SP in 2 weeks would look good in the trading account. Once we get thru .70 it should be a clean run out of penny status. Fingers are crossed. GLTA beech